Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia

NCT03823365 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia

Interventions

BIOLOGICAL: Blinatumomab Expanded T-cells (BET)

Sponsor

A.O. Ospedale Papa Giovanni XXIII